Richard Paulson

Richard Paulson

About

Detail

President and Chief Executive Officer
United States

Timeline


work
Job
school
Education

Résumé


Jobs verified_user 0% verified
  • Karyopharm Therapeutics Inc
    President and Chief Executive Officer
    Karyopharm Therapeutics Inc
    May 2021 - Current (5 years 2 months)
  • Ipsen
    Chief Executive Officer, Ipsen North America
    Ipsen
    Feb 2018 - May 2021 (3 years 4 months)
    Provide visionary leadership of Ipsen’s growing U.S. and Canadian markets across its key therapeutic areas of oncology, neuroscience and rare diseases. Serve as a member of Ipsen’s Global Executive Leadership Team and as Chair, Global Business Operations. Ipsen is a global biopharmaceutical company focused on innovation and specialty care. Ipsen’s resources, investments and energy are dedicated to discovering, developing and commercializing new therapeutic options to provide hope for patients, and their families, impacted by difficult-to-treat diseases.
  • Amgen
    Vice President & General Manager Oncology, U.S. Oncology Business Unit
    Amgen
    Oct 2015 - Feb 2018 (2 years 5 months)
    Recruited internally to lead $10B business and transform U.S. organization to transition from established portfolio to new, innovative and bio-similar portfolio in rapidly evolving U.S. environment.
  • Amgen
    Vice President Marketing, U.S. Oncology Business Unit
    Amgen
    Sep 2013 - Oct 2015 (2 years 2 months)
    Transformed U.S. marketing capabilities for $9B business. Elevated cross-functional collaboration with R&D. Rebuilt global and U.S. partnership while creating defensive bio-similar strategies for future off-patent products. Charged with integrating and leading $10B Onyx acquisition.
  • Amgen
    VP & General Manager, Germany
    Amgen
    Jan 2011 - Sep 2013 (2 years 9 months)
    Responsible for revenues in excess of US $600 million and 400 employees. Returned German affiliate to profitable growth, achieved double-digit revenue and profit growth. Adapted and prepared for new government reimbursement system. Launched major new products and defended against bio-similars.
  • Amgen
    Executive Director & General Manager, Central and Eastern Europe
    Amgen
    Mar 2008 - Feb 2011 (3 years)
    Responsible for revenues in excess of US $300 million and 300 employees across 11 countries. Led next phase of growth across Central and Eastern Europe while supporting Amgen’s emerging market international growth phase.
  • Pfizer
    CEO & Country Manager, Pfizer South Africa and Southern Africa
    Pfizer
    Sep 2005 - Feb 2008 (2 years 6 months)
    P&L responsibility with more than 400 employees, profit growth exceeded revenue growth. Developed and gained corporate approval for launch of first Pfizer affiliate generic company. Pfizer South Africa recognized as one of the Top South Africa Employers.
  • Pfizer
    CEO & General Manager, Czech Republic
    Pfizer
    May 2002 - Sep 2005 (3 years 5 months)
    P&L responsibility with more than 250 employees, profit growth exceeded revenue growth with revenue increasing 100% in 2 years. Led integration with Pharmacia.
  • Pfizer
    Director, Patient Access, Europe and Canada
    Pfizer
    Jan 2001 - Apr 2002 (1 year 4 months)
    Introduced new Value and Access capabilities to European affiliates, addressing changing payer demands, and ensuring successful launch of new products.
  • Pfizer
    Director, Patient Access & Health Policy, Canada
    Pfizer
    Jan 1999 - Dec 2001 (3 years)
    Created and championed new capability focused on public and private market access, government relations, employers and benefits consultants, pricing strategies, patient and professional association advocacy. Led Canadian integration with Parke Davis.
  • G
    Sales, Marketing & Market Access
    Glaxo Wellcome Canada Inc
    Jan 1989 - Dec 1999 (11 years)
    Held various roles in sales, marketing and market access with increasing levels of responsibility at Glaxo Wellcome in Canada.
Education verified_user 0% verified
  • University of Toronto  Rotman School of Management
    MBA, EMBA
    University of Toronto Rotman School of Management
    Jan 1994 - Dec 1996 (3 years)
  • University of Saskatchewan
    Bachelor of Commerce - BCom, Marketing and Finance
    University of Saskatchewan
    Jan 1986 - Dec 1989 (4 years)
This is a community-created genome.